Skip to main content
Trials logoLink to Trials
. 2023 Jan 24;24:55. doi: 10.1186/s13063-022-07036-8

Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)

I W J M van Goor 1,2,, L A Daamen 1,3, M G Besselink 4,5, A M E Bruynzeel 5,6, O R Busch 4,5, G A Cirkel 7, B Groot Koerkamp 8, N Haj Mohammed 7, H D Heerkens 9, H W M van Laarhoven 5,10, G J Meijer 2, J Nuyttens 11, H C van Santvoort 1, G van Tienhoven 5,12, H M Verkooijen 3, J W Wilmink 5,10, I Q Molenaar 1, M P W Intven 2,; for the Dutch Pancreatic Cancer Group
PMCID: PMC9875523  PMID: 36694252

Correction: Trials 23, 913 (2022)

https://doi.org/10.1186/s13063-022-06829-1

The original publication of this article [1] contained 2 redundant affiliations in the author information and in the “administrative information table”. These redundant affiliations (previously numbered nr. 2 and 10) have been deleted. The publisher apologizes to the author for the inconvenience caused.

Contributor Information

I. W. J. M. van Goor, Email: i.w.j.vangoor-5@umcutrecht.nl

M. P. W. Intven, Email: m.intven@umcutrecht.nl

Reference

  • 1.van Goor IWJM, et al. A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE) Trials. 2022;23:913. doi: 10.1186/s13063-022-06829-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Trials are provided here courtesy of BMC

RESOURCES